One of those, Climara,ceased production in mid-to-late 2023, putting extra demand on the remaining estrogen-only brands, Estradot and Estraderm, as well as the combination estrogen and progesterone patch, Estalis. Currently both Estradot and Estalis are in short supply—so the loss of just one...